Bridges Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bridges Investment Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,121	Closed	-$361K	–	404
2024 Q3	$361K	Hold	14,121	–	–	0.01%	323
2024 Q2	$332K	Buy	14,121 +517	+4%	+$13K	0.01%	323
2024 Q1	$391K	Hold	13,604	–	–	0.01%	171
2023 Q4	$446K	Sell	13,604 -735	-5%	-$20K	0.01%	168
2023 Q3	$399K	Hold	14,339	–	–	0.01%	170
2023 Q2	$489K	Hold	14,339	–	–	0.02%	170
2023 Q1	$431K	Buy	14,339 +1,110	+8%	+$34.4K	0.02%	176
2022 Q4	$373K	Sell	13,229 -1,419	-10%	-$45K	0.01%	180
2022 Q3	$481K	Hold	14,648	–	–	0.02%	175
2022 Q2	$461K	Hold	14,648	–	–	0.02%	178
2022 Q1	$673K	Buy	14,648 +4,455	+44%	+$212K	0.02%	166
2021 Q4	$624K	Buy	10,193 +4,245	+71%	+$293K	0.02%	174
2021 Q3	$444K	Hold	5,948	–	–	0.01%	181
2021 Q2	$550K	Hold	5,948	–	–	0.02%	174
2021 Q1	$528K	Hold	5,948	–	–	0.02%	173
2020 Q4	$555K	Buy	+5,948	New	+$474K	0.02%	162

Other funds holding ARKG

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bridges Investment Management's ARKG Position: Q4 2024 in Review

Bridges Investment Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 14,121 shares — an estimated $361K sold.

Bridges Investment Management first reported a position in ARKG in Q4 2020 and held it in 16 quarters. The position peaked at $673K in Q1 2022. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

Bridges Investment Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
Bridges Investment Management sold 14,121 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $361K.
Bridges Investment Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 16 quarters.
Bridges Investment Management's ARK Genomic Revolution ETF position peaked at $673K in Q1 2022.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Bridges Investment Management's 13F filing for Q4 2024, filed 5 Feb 2025.